CGON Q1 2026 Earnings EPS Miss as ClinicalStage Oncology Firm Reports No Revenue TXMD Q3 2023 Earnings A Significant EPS Miss Amid No Reported Revenue NMRA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase HMY Q2 2016 Earnings Heavy EPS Miss Weighs on Gold Miners Results UHAL Q1 2026 Earnings Massive EPS Miss Sends Caution Signals TLF Q1 2026 Earnings Modest Profitability Amid Quiet Quarter